Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.
Appendix B: Panel Roster and Financial Disclosures
Last Updated: November 1, 2016; Last Reviewed: November 1, 2016
|Dooley, Kelly||Johns Hopkins University School of Medicine||ViiV Healthcare||Research Support|
|George, Jomy||National Institutes of Health||None||N/A|
|Kuriakose, Safia||National Institutes of Health||None||N/A|
|Pau, Alice*||National Institutes of Health
|Peloquin, Charles||University of Florida||Astra Zeneca||Research Support|
|Jacobus Pharmaceuticals||Research Support|
|Pham, Paul||Westview Urgent Care||None||N/A|
* Group lead
Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from November 1, 2014, through November 1, 2016.
- CDC | 2015 STD Treatment Guidelines
- HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
- AIDSinfo Patient Materials: What is an Opportunistic Infection?
- AIDSource | HIV-Related Conditions
- AETC National HIV Curriculum
- How to Cite These Guidelines
- Adult and Adolescent OI Guidelines Archive